- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2012-000250-55. Displaying page 1 of 1.
|EudraCT Number: 2012-000250-55||Sponsor Protocol Number: RASQAL||Start Date*: 2012-07-12|
|Sponsor Name:Medizinische Universität Wien, Universitätsklinik für innere Medizin III|
|Full Title: Renin-Angiotensin System Quantification in patients treated with Aliskiren or Candesartan (RASQAL)|
|Medical condition: - Chronic kidney disease stages III-IV (defined by MDRD formula) - Hypertension|
|Population Age: Adults, Elderly||Gender: Male, Female|
|Trial protocol: AT (Completed)|
|Trial results: (No results available)|
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
|Number of Trials to download:|
• Outside EU/EEA: Date study was submitted in EudraCT
Query did not match any studies.